Potential applications of horseshoe crab in biomedical research
Keywords:
Horseshoe crab, perivitelline fluid, embryogenesis, cell differentiation, biomedicineAbstract
Horseshoe crab is one of the oldest existing living fossils comprising four main species today. Of these, Limulus Polyphemus is found in North America and the other three species, Tachypleus tridentatus, Tachypleus gigas and Carcinoscorpius rotundicauda are found in Southeast Asia. Horseshoe crabs play important roles in the regulation of the coastal ecology communities whereby the eggs serve as the main diet of shorebird species during the migrating season. Horseshoe crab is also seen as a versatile organism, useful in the biomedicine field particularly, as its blue blood has been widely integrated to be used for endotoxin tester in vaccines, drugs and injectables. Researchers have explored a material called perivitelline fluid (PVF) from the egg of a fertilized horseshoe crab which is rich in important proteins and amino acids that are crucial for embryogenesis. Previous studies have shown that PVF has the ability to enhance cell growth and differentiation as well as in promoting generation of certain organs. Testing of PVF on many types of cells has shown positive results and hence, it is suggested that PVF could be used as a supplement to support cell growth in future. Highlighting the horseshoe crab as a living fossil, this review brings out the relevance of the blue blood and PVF of the horseshoe crab as sources benefitting molecular research
References
Sekiguchi K. In: Biology of Horseshoe Crabs. Tokyo: Science House Co Ltd. pp. 1988;139-181.
Nagai T, Kawabata S, Shishikura F, Sugita H. Purification, characterization, and amino acid sequence of an embryonic lectin in perivitelline fluid of the horseshoe crab. The Journal of Biological Chemistry. 1999;274(53):37673-37678.
Villa FA, Gerwick L. Marine natural product drug discovery: Leads for treatment of inflammation, cancer, infections, and neurological disorders. Immunopharmacology and Immunotoxicology. 2010;32(2):228-237.
Chatterji A, Abdi SAH. The Indian horseshoe crab-A living fossil. Journal of Indian Ocean Studies. 1994;1:42-48.
Ehlinger GS, Tankersley RA. Survival and development of horseshoe crab (Limulus polyphemus) embryos and larvae in hypersaline conditions. Biological Bulletin. 2004;206(2):87–94.
Hicklin PW, Smith PC. Selection of foraging sites and invertebrate prey by migrant semipalmated sandpipers, Calidris pusilla (Pallas) in Minas Basin, Bay of Fundy. Canadian Journal of Zoology. 1984;62(11):2201-2210.
Mikkelsen T. The Secret in the Blue Blood. No. 134. 1988. Beijing: Science Press.
Rudkin DM, Young GA, Nowlan GS. The oldest horseshoe crab: a new xiphosurid from late Ordovician konservat-lagerstätten deposits, Manitoba, Canada. Palaeontology. 2008;51:1–9.
Shuster CN. A pictorial review of the natural history and ecology of the horseshoe crab Limulus polyphemus, with reference to other Limulidae. Progress in Clinical and Biological Research. 1982;81:1-52.
Krisfalusi-Gannon, J, Ali, W, Dellinger, K, Robertson, L, Brady, TE, Goddard, MKM, Tinker-Kulberg, R, Kepley, CL, Dellinger, AL. The role of horseshoe crabs in the biomedical industry and recent trends impacting species sustainability. Frontiers in Marine Science. 2018;5(185):1–13.
Levin J, Bang F. Clottable protein in Limulus; its localization and kinetics of its coagulation by endotoxin. Thrombosis et Diathesis Haemorrhagica. 1968;19(1):186-197.
Jorgenson JH, Smith RF. Preparation, sensitivity, and specificity of Limulus lysate for endotoxin assay. Applied Microbiology.1973;26(1):43-48.
Shoemaker R. Shrimp waste utilization. INFO FISH Technical Handbook 4. INFOFISH Technical Handbook Series, Canada. 1991;1-10.
Austin PR, Brine CJ, Castle JE, Zikakis JP. Chitin: new face of research. Science. 1981;212:749-753.
Benjakul S, Sophanodora P. Chitosan production from carapace and shell of black tiger shrimp (Penaeusmonodon). ASEAN Food Journal. 1993;8:145-148.
Das NG, Khan PA, Hossain Z. Chitin from the shell of two coastal portunid crabs of Bangladesh. Indian Journal of Fisheries. 1996;43:413-415.
Johnson JT, Hopkins TL. (1978). Biochemical components of the mysid shrimp Taphromysis bowmani Bacescu. Journal of Experimental Marine Biology and Ecology. 1978;31:1-9.
Ramachandran Nair KG, Madhavan P, Gopakumar K. Novel use of chitinous waste from crustacean processing plants. INFO FISH Marketing Digest. 1986;4/86:20.
Simpson BK, Gagne N, Ashie INA, Noroozi E. Utilization of chitosan for preservation of raw shrimp (Pandullus borealis). Food Biotechnology. 1997;11:25-44.
Van Ornum J. Shrimp waste - must it be wasted? Proceedings of the 3rd Global conference on the shrimp industry. Hong Kong. Infofish. 1992;158-164.
Parab PB, Ghaskadbi S, Patwardhan V, Mishra GC, Chatterji A, Parameswaran PS. 2004. Patent Number: 0319NF2004. USA: US Patent.
Shishikura F, Sekiguchi K. Studies on peri-vitelline fluid of horseshoe crab embryo. II. Purification of agglutinin-binding substance from the peri-vitelline fluid of Tachypleus gigas embryo. The Journal of Biological Chemistry. 1984;96(3):629-636.
Nagai T, Osaki T, Kawabata S. Functional conversion of hemocyanin to phenol oxidase by horseshoe crab antimicrobial peptides. The Journal of Biological Chemistry. 2001;276(29):27166-27170.
Ghaskadbi S, Patwardhan V, Chakraborthy M, Agrawal S, Verma MK, Chatterjee A, Lenka N, Parab PB. Enhancement of vertebrate cardiogenesis by a lectin from perivitelline fluid of horseshoe crab embryo. Cellular and Molecular Life Sciences. 2008;65(20): 3312-3324.
Singh R, Bhari R, Kaur HP. Characteristics of yeast lectins and their role in cell–cell interactions. Biotechnology Advances. 2011;29(6):726-731.
Srijaya TC, Pradeep PJ, Hassan A, Chatterji A, Shaharom F. Effect of perivitelline fluid from horseshoe crab embryo in enhancing the early gonadal development in red tilapia. Biological Forum – An International Journal. 2013;5(2):1-7.
Marahaini M, Khadijah MA, Kannan TP, Ahmad A, Nor Shamsuria O, Chatterji A, Khairani IM. Effects of perivitelline fluid obtained from horseshoe crab on the proliferation and genotoxicity of dental pulp stem cells. Cell Journal. 2015;17(2):253-263.
Alam H, Sumedha C, Pati S, Dash BP, Chatterji A. Horseshoe Crab Peri-vitelline fluid triggers the human bone marrow stem cell differentiation into cardiomyocyte In Vitro. Cell and Development Biology. 2015;4(13):1-5.
Berkson, J, Shuster Jr C. The horseshoe crab: the battle for a true multipleâ€use resource. Fisheries. 1999;24(11):6-10.
Ding JL, Ho B. A new era in pyrogen testing. Trends in Biotechnology. 2001;19(8):277-281.
Kumar V, Roy S, Sahoo A, Kumar V. Horseshoe crabs: biomedical importance and its potential use in developing health-care products. NISCAIR-CSIR. 2016. India.
Sperstad SV, Haug T, Blencke HM, Styrvold O, Stensvåg K. Antimicrobial peptides from marine invertebrates: challenges and perspectives in marine antimicrobial peptide discovery. Biotechnology Advances. 2011;9(5):519-530.
Walls EA, Berkson J. Effects of blood extraction on horseshoe crabs (Limulus polyphemus). Fishery bulletin. 2003;101(2):457-459.
Downloads
Additional Files
Published
Issue
Section
License
JBCS Publication Ethics
JBCS is committed to ensure the publication process follows specific academic ethics. Hence, Authors, Reviewers and Editors are required to conform to standards of ethical guidelines.
Authors
Authors should discuss objectively the significance of research work, technical detail and relevant references to enable others to replicate the experiments. JBCS do not accept fraudulent or inaccurate statements that may constitute towards unethical conduct.
Authors should ensure the originality of their works. In cases where the work and/or words of others have been used, appropriate acknowledgements should be made. JBCS do not accept plagiarism in all forms that constitute towards unethical publishing of an article.
This includes simultaneous submission of the same manuscript to more than one journal. Corresponding author is responsible for the full consensus of all co-authors in approving the final version of the paper and its submission for publication.
Reviewers
Reviewers of JBCS treat manuscripts received for review as confidential documents. Therefore, Reviewers must ensure the confidentiality and should not use privileged information and/or ideas obtained through peer review for personal advantage.
Reviews should be conducted based on academic merit and observations should be formulated clearly with supporting arguments. In cases where selected Reviewer feels unqualified to review a manuscript, Reviewer should notify the editor and excuse himself from the review process in TWO (2) weeks time from the review offer is made.
In any reasonable circumstances, Reviewers should not consider to evaluate manuscripts if they have conflicts of interest (i.e: competitive, collaborative and/or other connections with any of the authors, companies, or institutions affiliated to the papers).
Editors
Editors should evaluate manuscripts exclusively based on their academic merit. JBCS strictly do not allow editors to use unpublished information of authors without the written consent of the author. Editors are required to take appropriate responsive actions if ethical complaints have been presented concerning a submitted manuscript or published paper.
CONFLICT OF INTEREST
Journal of Biomedical and Clinical Sciences requires authors to declare all competing interests in relation to their work. All submitted manuscripts must include a ‘competing interests section at the end of the manuscript listing all competing interests (financial and non-financial). Where authors have no competing interests, the statement should read ,The authors have declared that no competing interests exist. Editors may ask for further information relating to competing interests.
Editors and reviewers are also required to declare any competing interests and will be excluded from the peer review process if a competing interest exists. Competing interests may be financial or non-financial. A competing interest exists when the authors interpretation of data or presentation of information may be influenced by their personal or financial relationship with other people or organizations. Authors should disclose any financial competing interests but also any non-financial competing interests that may cause them embarrassment if they were to become public after the publication of the article.
HUMAN AND ANIMAL RIGHTS
All research must have been carried out within an appropriate ethical framework. If there is suspicion that work has not taken place within an appropriate ethical framework, Editors will follow the Misconduct policy and may reject the manuscript, and/or contact the author(s) institution or ethics committee. On rare occasions, if the Editor has serious concerns about the ethics of a study, the manuscript may be rejected on ethical grounds, even if approval from an ethics committee has been obtained.
Research involving human subjects, human material, or human data, must have been performed in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee. A statement detailing this, including the name of the ethics committee and the reference number where appropriate, must appear in all manuscripts reporting such research. Further information and documentation to support this should be made available to Editors on request.
Experimental research on vertebrates or any regulated invertebrates must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. The Basel Declaration outlines fundamental principles to adhere to when conducting research in animals and the International Council for Laboratory Animal Science (ICLAS) has also published ethical guidelines.
A statement detailing compliance with relevant guidelines (e.g. the revised Animals (Scientific Procedures) Act 1986 in the UK and Directive 2010/63/EU in Europe) and/or ethical approval (including the name of the ethics committee and the reference number where appropriate) must be included in the manuscript. The Editor will take account of animal welfare issues and reserves the right to reject a manuscript, especially if the research involves protocols that are inconsistent with commonly accepted norms of animal research. In rare cases, Editors may contact the ethics committee for further information.
INFORMED CONSENT
For all research involving human subjects, informed consent to participate in the study should be obtained from participants (or their parent or guardian in the case of children under 16) and a statement to this effect should appear in the manuscript, this includes to all manuscripts that include details, images, or videos relating to individual participants.
DATA SHARING POLICY
JBCS strongly encourages that all datasets on which the conclusions of the paper rely should be available to readers. We encourage authors to ensure that their datasets are either deposited in publicly available repositories (where available and appropriate) or presented in the main manuscript or additional supporting files, in machine-readable format (such as spreadsheets rather than PDFs) whenever possible
Authors who do not wish to share their data must state that data will not be shared, and give the reason.
COPYRIGHT NOTICE
The JBCS retains the copyright of published manuscripts under the terms of the Copyright Transfer Agreement. However, the journal permits unrestricted use, distribution, and reproduction in any medium, provided permission to reuse, distribute and reproduce is obtained from the Journal's Editor and the original work is properly cited.
While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
Copyright (c) 2023 Journal of Biomedical and Clinical Sciences (JBCS)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
